Co-mapping clonal and transcriptional heterogeneity in somatic evolution via GoT-Multi

Comprehensive Summary

This study by Pak et al. applies single-cell genomics to co-map clonal genetic diversity and cell-state heterogeneity within cancer, focusing on therapy-resistant lymphomas. Using an integrated analytical approach (referred to as GoT-Multi), the authors profile individual cancer cells to reveal how genetically distinct clones within tumors exhibit convergent transcriptional states, even when their underlying mutations differ. This work demonstrates that trajectories inferred from bulk sequencing can be resolved using single-cell resolution, revealing complex patterns of clonal diversification and transcriptional programs that are associated with resistance and disease progression.

Outcomes and Implications

The findings hihglight the power of single-cell genomics to deconvolve both genotype and gene expression within the same cells, showing how diverse cancer clones can adopt similar states that contribute to therapy resistance. This co-mapping approach may improve understanding of how clonal evolution shapes tumor behavior, potentially informing personalized therapeutic strategies that target shared cellular states rather than individual mutations. This work contributes to the evolution of precision oncology, helping clinicians anticipate resistance mechanisms and tailor treatments accordingly.